Filing Details

(1) See Note 1 to Item 5 below.

The following constitutes Amendment No 2 (“Amendment No. 2”) to the Schedule 13D filed by the undersigned.  This Amendment No. 2 amends the Schedule 13D as specifically set forth herein.

Item 2(b) is hereby amended to read as follows:

(b) The principal business address of the Reporting Person is 1133 Avenue of the Americas, 33^rd Floor, New York, New York 10036.

Item 3 is hereby amended to add the following:

The consideration for the purchase of the securities on September 2, 2020 reported herein by the Reporting Person was derived from available capital of the Funds managed by Paulson, and a total of approximately $3,272,374 was paid to acquire such securities.

Item 4 is hereby amended to add the following:

On, August 31, 2020, the Issuer entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (“B. Riley”), pursuant to which the Issuer will be entitled, at its discretion and from time-to-time during the term of the Sales Agreement, to sell through B. Riley such number of common shares of the Company as would result in aggregate gross proceeds to the Company of up to $10,300,000 (the “Offering”). The foregoing description of the Sales Agreement is qualified in its entirety by reference to Exhibit 1.1 to Issuer’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 1, 2020. On September 2, 2020, the Reporting Person acquired an additional 2,337,410 shares of Common Stock pursuant to the Offering.

Item 5 is hereby amended and restated to read as follows:

(a)            The aggregate percentage of Common Stock reported owned by the Reporting Person is based upon approximately 193,244,668 shares of Common Stock outstanding, which is based upon (i) 187,573,671 shares of Common Stock outstanding as of July 31, 2020 as disclosed in the Issuer’s Current Report on Form 10-Q filed with the Securities and Exchange Commission on August 10, 2020 and (ii) the issuance by the Issuer of an additional 5,670,997 shares of Common Stock as described in the Sales Agreement. As of the date hereof, the Reporting Person may be deemed to have beneficially owned approximately 32.0% of the outstanding Common Stock.

(b)            Number of shares of Common Stock as to which Paulson has:

(i) Sole power to vote or direct the vote: 61,930,724 (see Note 1).

(ii) Shared power to vote or direct the vote: 0

(iii) Sole power to dispose or direct the disposition: 61,930,724 (see Note 1).

(iv) Shared power to dispose or direct the disposition: 0

(c)            On September 2, 2020, the Reporting Person acquired from the Issuer, in a private placement, 2,337,410  shares of Common Stock at a price of $1.40 per share.

(d)            See Note 1.

(e)            Not applicable.

Note 1: Paulson, an investment advisor that is registered under the Investment Advisers Act of 1940, furnishes investment advice to and manages the Funds. In its role as investment advisor, or manager, as the case may be, Paulson possesses voting and investment power over the securities of the Issuer described in this Schedule 13D that are owned by the Funds. The pecuniary interest of all securities reported in this Schedule is owned by the Funds. Except for the purpose of determining beneficial ownership under Section 13(d) of the Securities Exchange Act of 1934, as amended, Paulson disclaims beneficial ownership of all securities reported in this Schedule 13D.

For reporting purposes, the aggregate amount of Common Stock deemed to be beneficially owned by the Reporting Person is calculated based on an aggregate of 61,930,724 shares of Common Stock beneficially held by the Reporting Person as of the date hereof.

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

Dated:  September 4, 2020